Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,469 | 264 | 99.4% |
| Education | $21.00 | 1 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Medtronic, Inc. | $1,518 | 128 | $0 (2024) |
| Collegium Pharmaceutical, Inc. | $954.36 | 84 | $0 (2024) |
| Nevro Corp. | $258.44 | 11 | $0 (2024) |
| TerSera Therapeutics LLC | $183.19 | 12 | $0 (2024) |
| ABBVIE INC. | $181.89 | 10 | $0 (2024) |
| Biohaven Pharmaceuticals, Inc. | $83.94 | 2 | $0 (2021) |
| SCILEX PHARMACEUTICALS INC. | $82.74 | 5 | $0 (2024) |
| Boston Scientific Corporation | $53.66 | 1 | $0 (2024) |
| USWM, LLC | $26.32 | 2 | $0 (2023) |
| BioDelivery Sciences International, Inc. | $25.28 | 2 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,406 | 86 | Medtronic, Inc. ($658.97) |
| 2023 | $889.19 | 74 | Medtronic, Inc. ($421.77) |
| 2022 | $558.87 | 57 | Medtronic, Inc. ($273.53) |
| 2021 | $636.00 | 48 | Medtronic, Inc. ($163.63) |
All Payment Transactions
265 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $24.15 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 12/30/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $11.12 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 12/23/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $29.04 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 12/16/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $18.80 | General |
| Category: Opioid Analgesic | ||||||
| 12/13/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $75.38 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 12/12/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $13.57 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 12/05/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $16.28 | General |
| Category: Opioid Analgesic | ||||||
| 12/02/2024 | TerSera Therapeutics LLC | Prialt (Drug) | Food and Beverage | In-kind items and services | $22.30 | General |
| Category: Pain Management | ||||||
| 12/02/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $15.83 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 11/26/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $20.10 | General |
| Category: Opioid Analgesic | ||||||
| 11/14/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $17.11 | General |
| Category: Opioid Analgesic | ||||||
| 11/14/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $9.73 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 11/11/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $10.41 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 11/08/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $8.19 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 10/31/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $16.19 | General |
| Category: Spinal Cord Stimulator | ||||||
| 10/24/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $22.20 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 10/24/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $19.43 | General |
| Category: Opioid Analgesic | ||||||
| 10/17/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $9.13 | General |
| Category: Opioid Analgesic | ||||||
| 10/17/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $7.13 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 10/15/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $10.01 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 10/10/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $18.62 | General |
| Category: Opioid Analgesic | ||||||
| 10/03/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $19.68 | General |
| Category: Analgesic | ||||||
| 10/01/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $14.24 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 09/26/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $21.85 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 09/26/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $19.26 | General |
| Category: Opioid Analgesic | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 383 | 764 | $122,673 | $48,940 |
| 2022 | 5 | 407 | 809 | $119,287 | $51,259 |
| 2021 | 8 | 493 | 1,100 | $133,794 | $58,595 |
| 2020 | 9 | 551 | 1,168 | $135,115 | $50,669 |
All Medicare Procedures & Services
27 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 156 | 378 | $75,050 | $27,964 | 37.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 115 | 199 | $27,516 | $9,993 | 36.3% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2023 | 79 | 149 | $13,069 | $8,706 | 66.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 22 | 22 | $6,270 | $2,135 | 34.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 11 | 16 | $768.00 | $142.08 | 18.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 153 | 356 | $66,312 | $26,000 | 39.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 121 | 235 | $29,375 | $12,013 | 40.9% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2022 | 81 | 164 | $13,940 | $9,563 | 68.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 24 | 24 | $6,840 | $2,473 | 36.2% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 28 | 30 | $2,820 | $1,210 | 42.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 170 | 391 | $72,435 | $30,030 | 41.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 131 | 245 | $30,625 | $12,194 | 39.8% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2021 | 99 | 198 | $16,830 | $11,631 | 69.1% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 36 | 36 | $10,260 | $3,680 | 35.9% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 17 | 19 | $1,680 | $864.19 | 51.4% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 15 | 27 | $1,296 | $174.17 | 13.4% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2021 | 14 | 150 | $600.00 | $13.67 | 2.3% |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | Office | 2021 | 11 | 34 | $68.00 | $7.84 | 11.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 174 | 353 | $65,305 | $21,166 | 32.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 155 | 305 | $38,125 | $13,141 | 34.5% |
| 80307 | Testing for presence of drug | Office | 2020 | 109 | 198 | $16,830 | $11,356 | 67.5% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 38 | 38 | $10,830 | $3,689 | 34.1% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 18 | 21 | $1,650 | $965.01 | 58.5% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2020 | 16 | 32 | $1,536 | $276.66 | 18.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2020 | 13 | 13 | $143.00 | $35.03 | 24.5% |
About Heather Hambrick, NP
Heather Hambrick, NP is a Nurse Practitioner healthcare provider based in Johnson City, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/02/2007. The National Provider Identifier (NPI) number assigned to this provider is 1780705434.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Heather Hambrick, NP has received a total of $3,490 in payments from pharmaceutical and medical device companies, with $1,406 received in 2024. These payments were reported across 265 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($3,469).
As a Medicare-enrolled provider, Hambrick has provided services to 1,834 Medicare beneficiaries, totaling 3,841 services with total Medicare billing of $209,462. Data is available for 4 years (2020–2023), covering 27 distinct procedure/service records.
Practice Information
- Specialty Nurse Practitioner
- Location Johnson City, TN
- Active Since 04/02/2007
- Last Updated 10/07/2025
- Taxonomy Code 363L00000X
- Entity Type Individual
- NPI Number 1780705434
Products in Payments
- INTELLIS ADAPTIVESTIM (Device) $1,335
- Belbuca (Drug) $477.66
- XTAMPZA (Drug) $472.76
- Prialt (Drug) $183.19
- Senza (Device) $166.39
- INTELLIS (Device) $134.77
- UBRELVY (Drug) $109.28
- NURTEC ODT (Drug) $100.11
- Omnia (Device) $92.05
- ZTLido (Drug) $82.74
- BOTOX (Biological) $72.61
- WaveWriter Alpha Prime 16 (Device) $53.66
- ZIMHI (Drug) $26.32
- BELBUCA (Drug) $25.28
- Kloxxado (Drug) $21.00
- Accurian (Device) $18.60
- NAPRELAN (Drug) $18.34
- Stimrouter Implantable Kit (Device) $16.61
- LICART (Drug) $14.65
- REYVOW (Drug) $12.80
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nurse Practitioner Doctors in Johnson City
Kelly Wilmarth, C-Fnp, C-FNP
Nurse Practitioner — Payments: $24,990
Abbie Harris, Fnp, FNP
Nurse Practitioner — Payments: $15,127
Shelly Howard, Np-C, NP-C
Nurse Practitioner — Payments: $14,441
Brandy Story, Np, NP
Nurse Practitioner — Payments: $13,625
Donna Gardner, Fnp, FNP
Nurse Practitioner — Payments: $9,901
Mrs. Shandon Morrison, N.p, N.P
Nurse Practitioner — Payments: $9,665